TrialJournal of neurology2026

Health-related quality of life outcomes with nipocalimab versus placebo in generalized myasthenia gravis: an analysis of the Vivacity-MG3 study.

John Vissing et al.PubMed ↗Publisher ↗

No numbers read from the abstract.